Page last updated: 2024-10-26

famotidine and Dysphagia

famotidine has been researched along with Dysphagia in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Research Excerpts

ExcerptRelevanceReference
"Heartburn, regurgitation and dysphagia were hardly found in any group at 8 weeks after 15 mg or 30 mg lansoprazole treatment."5.11Management of symptoms in step-down therapy of gastroesophageal reflux disease. ( Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stokes, NA1
Lemos, JP1
Mine, S1
Iida, T1
Tabata, T1
Kishikawa, H1
Tanaka, Y1

Trials

1 trial available for famotidine and Dysphagia

ArticleYear
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibit

2005

Other Studies

1 other study available for famotidine and Dysphagia

ArticleYear
Male patient with throat swelling and painful swallowing.
    The Journal of emergency medicine, 2013, Volume: 44, Issue:6

    Topics: Adenoids; Adult; Angioedema; Anti-Inflammatory Agents; Deglutition Disorders; Dexamethasone; Diphenh

2013